{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:43:48Z","timestamp":1761061428604,"version":"3.44.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.cbi.2021.109521","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T09:25:29Z","timestamp":1622107529000},"page":"109521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, blocks steatosis and alters the inflammatory response in a mouse model of inflammation-dioxin interaction"],"prefix":"10.1016","volume":"345","author":[{"given":"Jesus","family":"Olivero-Verbel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack R.","family":"Harkema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia E.","family":"Ganey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cbi.2021.109521_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11356-018-3629-z","article-title":"Monitoring polychlorinated dibenzo-p-dioxins\/dibenzofurans and dioxin-like polychlorinated biphenyls in Africa since the implementation of the Stockholm Convention-an overview","volume":"26","author":"Pius","year":"2019","journal-title":"Environ. Sci. Pollut. Res. Int."},{"issue":"2","key":"10.1016\/j.cbi.2021.109521_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.toxlet.2013.10.039","article-title":"AhR signalling and dioxin toxicity","volume":"230","author":"Sorg","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2021.109521_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tox.2006.04.045","article-title":"The constitutively active Ah receptor (CA-Ahr) mouse as a potential model for dioxin exposure - effects in vital organs","volume":"224","author":"Brunnberg","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2021.109521_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0041-008X(83)90326-5","article-title":"Liver morphology in Guinea pigs administered either pyrolysis products of a polychlorinated biphenyl transformer fluid or 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"67","author":"Turner","year":"1983","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109521_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/00039896.1981.10667598","article-title":"The development and prognosis of chronic intoxication by tetrachlordibenzo-p-dioxin in men","volume":"36","author":"Pazderova-Vejlupkov\u00e1","year":"1981","journal-title":"Arch. Environ. Health"},{"key":"10.1016\/j.cbi.2021.109521_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/toxsci\/kft028","article-title":"Comparative analysis of temporal and dose-dependent TCDD-elicited gene expression in human, mouse, and rat primary hepatocytes","volume":"133","author":"Forgacs","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2021.109521_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/toxsci\/kft156","article-title":"Toxicogenomic evaluation of long-term hepatic effects of TCDD in immature, ovariectomized C57BL\/6 mice","volume":"135","author":"Kopec","year":"2013","journal-title":"Toxicol. Sci."},{"issue":"6","key":"10.1016\/j.cbi.2021.109521_bib8","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/ijms21062061","article-title":"PPARs as metabolic regulators in the liver: lessons from liver-Specific PPAR-null mice","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2021.109521_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/3-540-27661-0_14","volume":"170","author":"Robillard","year":"2005","journal-title":"Fibrates. Handb Exp Pharmacol."},{"issue":"7","key":"10.1016\/j.cbi.2021.109521_bib10","doi-asserted-by":"crossref","first-page":"E2148","DOI":"10.3390\/ijms19072148","article-title":"The peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) agonist pemafibrate protects against diet-induced obesity in mice","volume":"19","author":"Araki","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2021.109521_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1358\/dot.2006.42.1.893618","article-title":"Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism","volume":"42","author":"Fruchart","year":"2006","journal-title":"Drugs Today"},{"key":"10.1016\/j.cbi.2021.109521_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/384039a0","article-title":"The PPARalpha-leukotriene B4 pathway to inflammation control","volume":"384","author":"Devchand","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2021.109521_bib13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/31701","article-title":"Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators","volume":"393","author":"Staels","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2021.109521_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/tox.21885","article-title":"The combined effects of DEHP and PCBs on phospholipase in the livers of mice","volume":"30","author":"Lin","year":"2015","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.cbi.2021.109521_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.tox.2005.07.020","article-title":"PPARalpha activation potentiates AhR-induced CYP1A1 expression","volume":"216","author":"Fallone","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2021.109521_bib16","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1292\/jvms.66.1377","article-title":"Down regulation of hepatic PPARalpha function by AhR ligand","volume":"66","author":"Shaban","year":"2004","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.cbi.2021.109521_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/00498250400021804","article-title":"AhR and PPARalpha: antagonistic effects on CYP2B and CYP3A, and additive inhibitory effects on CYP2C11","volume":"35","author":"Shaban","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2021.109521_bib18","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1289\/ehp.1103593","article-title":"Aryl hydrocarbon receptor deficiency enhances insulin sensitivity and reduces PPAR-\u03b1 pathway activity in mice","volume":"119","author":"Wang","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.cbi.2021.109521_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/toxsci\/kfm272","article-title":"In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effects on fetal and adult cardiac gene expression and adult cardiac and renal morphology","volume":"101","author":"Aragon","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2021.109521_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/10408390600919015","article-title":"Interactions among infections, nutrients and xenobiotics","volume":"47","author":"Illb\u00e4ck","year":"2007","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.cbi.2021.109521_bib21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3164\/jcbn.09-50","article-title":"Development of fibrosis in nonalcoholic steatosis through combination of a synthetic diet rich in disaccharide and low-dose lipopolysaccharides in the livers of Zucker (fa\/fa) rats","volume":"45","author":"Fukunishi","year":"2009","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.cbi.2021.109521_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0765.2009.01212.x","article-title":"Effects of topical application of lipopolysaccharide and proteases on hepatic injury induced by high-cholesterol diet in rats","volume":"45","author":"Yamamoto","year":"2010","journal-title":"J. Periodontal. Res."},{"key":"10.1016\/j.cbi.2021.109521_bib23","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jn\/138.8.1452","article-title":"Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake","volume":"138","author":"Thuy","year":"2008","journal-title":"J. Nutr."},{"key":"10.1016\/j.cbi.2021.109521_bib24","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/jat.1243","article-title":"Characterization of a lipopolysaccharide mediated neutrophilic hepatitis model in Sprague Dawley rats","volume":"27","author":"Rose","year":"2007","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.cbi.2021.109521_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1020278104132","article-title":"Cytokine-induced neutrophil chemoattractant in a rat model of lipopolysaccharide-induced acute lung injury","volume":"23","author":"Yamasawa","year":"1999","journal-title":"Inflammation"},{"key":"10.1016\/j.cbi.2021.109521_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2249.2001.01370.x","article-title":"Neutrophil accumulation induced by bacterial lipopolysaccharide: effects of dexamethasone and annexin 1","volume":"123","author":"Allcock","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cbi.2021.109521_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.intimp.2017.03.001","article-title":"Interleukin-23 mediates the pathogenesis of LPS\/GalN-induced liver injury in mice","volume":"46","author":"Bao","year":"2017","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.cbi.2021.109521_bib28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbrc.2012.09.088","article-title":"The anti-inflammatory effects of ethyl acetate on Lipopolysaccharide\/D-galactosamine challenged mice and Lipopolysaccharide activated RAW264.7 cells","volume":"427","author":"Liu","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2021.109521_bib29","first-page":"147","article-title":"D-galactosamine lethality model: scope and limitations","volume":"10","author":"Silverstein","year":"2004","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.cbi.2021.109521_bib30","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1073\/pnas.76.11.5939","article-title":"Galactosamine-induced sensitization to the lethal effects of endotoxin","volume":"76","author":"Galanos","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2021.109521_bib31","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.fct.2018.07.053","article-title":"Diallyl sulfide protects against lipopolysaccharide\/d-galactosamine-induced acute liver injury by inhibiting oxidative stress, inflammation and apoptosis in mice","volume":"120","author":"Li","year":"2018","journal-title":"Food Chem. Toxicol."},{"issue":"9","key":"10.1016\/j.cbi.2021.109521_bib32","first-page":"4271","article-title":"Oridonin ameliorates lipopolysaccharide\/D-galactosamine-induced acute liver injury in mice via inhibition of apoptosis","volume":"9","author":"Deng","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.cbi.2021.109521_bib33","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.2353\/ajpath.2007.061056","article-title":"Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice","volume":"170","author":"Le Minh","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cbi.2021.109521_bib34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1872-034X.2007.00252.x","article-title":"Effects of free radical scavenger on acute liver injury induced by d-galactosamine and lipopolysaccharide in rats","volume":"38","author":"Ito","year":"2007","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.cbi.2021.109521_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejphar.2015.12.043","article-title":"Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model","volume":"772","author":"Orime","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109521_bib36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejphar.2009.02.024","article-title":"Fenofibrate ameliorates diabetic and dyslipidemic profiles in KKAy mice partly via down-regulation of 11beta-HSD1, PEPCK and DGAT2. Comparison of PPARalpha, PPARgamma, and liver x receptor agonists","volume":"607","author":"Srivastava","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109521_bib37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.taap.2012.11.009","article-title":"2,3,7,8-TCDD enhances the sensitivity of mice to concanavalin A immune-mediated liver injury","volume":"266","author":"Fullerton","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109521_bib38","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1080\/02772248.2011.577554","article-title":"Dioxin alters inflammatory responses to lipopolysaccharide","volume":"93","author":"Olivero-Verbel","year":"2011","journal-title":"Toxicol. Environ. Chem."},{"key":"10.1016\/j.cbi.2021.109521_bib39","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/toxsci\/67.2.322","article-title":"Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis?","volume":"67","author":"Gujral","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2021.109521_bib40","first-page":"935","article-title":"Demonstration of extensive chromatin cleavage in transplanted Morris hepatoma 7777 tissue: apoptosis or necrosis?","volume":"142","author":"Fukuda","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cbi.2021.109521_bib41","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.lfs.2003.10.021","article-title":"Secoisolariciresinol and isotaxiresinol inhibit tumor necrosis factor-alpha-dependent hepatic apoptosis in mice","volume":"74","author":"Banskota","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2021.109521_bib42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1758-5996-4-32","article-title":"Diet high in fat and sucrose induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation in mice","volume":"4","author":"Yang","year":"2012","journal-title":"Diabetol. Metab. Syndrome"},{"issue":"2","key":"10.1016\/j.cbi.2021.109521_bib43","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/toxsci\/kfi162","article-title":"Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-Mediated hepatotoxicity","volume":"85","author":"Boverhof","year":"2005","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.cbi.2021.109521_bib44","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/toxsci\/kfw175","article-title":"From the cover: coagulation-driven hepatic fibrosis requires protease activated receptor-1 (PAR-1) in a mouse model of TCDD-elicited steatohepatitis","volume":"154","author":"Nault","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2021.109521_bib45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/17512433.2017.1300059","article-title":"Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes","volume":"10","author":"Cernea","year":"2017","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109521_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2013.09.001","article-title":"Obesity and liver cancer","volume":"18","author":"Vanni","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.cbi.2021.109521_bib47","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.arcmed.2006.09.001","article-title":"Hepatitis C and steatosis","volume":"38","author":"Bj\u00f6rnsson","year":"2007","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.cbi.2021.109521_bib48","doi-asserted-by":"crossref","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","article-title":"Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation","volume":"290","author":"Reddy","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.cbi.2021.109521_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jgh.12251","article-title":"Non-alcoholic fatty liver disease: factors associated with its presence and onset","volume":"28","author":"Miyake","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2021.109521_bib50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tox.2007.03.012","article-title":"Differences in acute toxicity syndromes of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in rats","volume":"235","author":"Niittynen","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2021.109521_bib51","doi-asserted-by":"crossref","first-page":"S399","DOI":"10.1016\/j.chemosphere.2006.05.135","article-title":"Long-term effects of subcutaneously injected 2,3,7,8-tetrachlorodibenzo-p-dioxin on the liver of rhesus monkeys","volume":"67","author":"Korenaga","year":"2007","journal-title":"Chemosphere"},{"key":"10.1016\/j.cbi.2021.109521_bib52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/15287390500244972","article-title":"Fatty liver and hepatic function for residents with markedly high serum PCDD\/Fs levels in Taiwan","volume":"69","author":"Lee","year":"2006","journal-title":"J. Toxicol. Environ. Health"},{"issue":"4","key":"10.1016\/j.cbi.2021.109521_bib53","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1021\/acs.chemrestox.6b00430","article-title":"Lipidomic evaluation of aryl hydrocarbon receptor-mediated hepatic steatosis in male and female mice elicited by 2,3,7,8-Tetrachlorodibenzo-p-dioxin","volume":"30","author":"Nault","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2021.109521_bib54","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4254\/wjh.v5.i9.470","article-title":"Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease","volume":"5","author":"Kostapanos","year":"2013","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.cbi.2021.109521_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006796","article-title":"Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human","volume":"4","author":"Rakhshandehroo","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.cbi.2021.109521_bib56","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1073\/pnas.96.13.7473","article-title":"A critical role for the peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) in the cellular fasting response: the PPAR\u03b1-null mouse as a model of fatty acid oxidation disorders","volume":"96","author":"Leone","year":"1999","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.cbi.2021.109521_bib57","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI6223","article-title":"Peroxisome proliferator-activated receptor \u03b1 mediates the adaptive response to fasting","volume":"103","author":"Kersten","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"29","key":"10.1016\/j.cbi.2021.109521_bib58","doi-asserted-by":"crossref","first-page":"15378","DOI":"10.1074\/jbc.M116.715151","article-title":"Hepatic aryl hydrocarbon receptor attenuates fibroblast growth factor 21 expression","volume":"291","author":"Girer","year":"2016","journal-title":"Biol. Chem."},{"key":"10.1016\/j.cbi.2021.109521_bib59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severly obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterol."},{"key":"10.1016\/j.cbi.2021.109521_bib60","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.1840120505","article-title":"Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors","volume":"12","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2021.109521_bib61","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1478-3231.2008.01723.x","article-title":"Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis","volume":"28","author":"Farhadi","year":"2008","journal-title":"Liver Int."},{"key":"10.1016\/j.cbi.2021.109521_bib62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/15287390903249057","article-title":"Bacterial- and viral-induced inflammation increases sensitivity to acetaminophen hepatotoxicity","volume":"73","author":"Maddox","year":"2010","journal-title":"J. Toxicol. Environ. Health"},{"issue":"2","key":"10.1016\/j.cbi.2021.109521_bib63","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/toxsci\/kft009","article-title":"Assessment of emerging biomarkers of liver injury in human subjects","volume":"132","author":"Schomaker","year":"2013","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2021.109521_bib64","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.abb.2007.07.023","article-title":"Isoforms of alanine aminotransferases in human tissues and serum--differential tissue expression using novel antibodies","volume":"466","author":"Lindblom","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"issue":"6","key":"10.1016\/j.cbi.2021.109521_bib65","doi-asserted-by":"crossref","first-page":"891","DOI":"10.33549\/physiolres.933304","article-title":"Hepatotoxic effects of fenofibrate in spontaneously hypertensive rats expressing human C-reactive protein","volume":"65","author":"\u0160kop","year":"2016","journal-title":"Physiol. Res."},{"issue":"2","key":"10.1016\/j.cbi.2021.109521_bib66","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.taap.2011.07.019","article-title":"Nrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitis","volume":"256","author":"Lu","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109521_bib67","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/carcin\/21.5.881","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits growth factor withdrawal-induced apoptosis in the human mammary epithelial cell line, MCF-10A","volume":"21","author":"Davis","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cbi.2021.109521_bib68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.tox.2005.09.002","article-title":"Characterization of anti-apoptotic action of TCDD as a defensive cellular stress response reaction against the cell damaging action of ultra-violet irradiation in an immortalized normal human mammary epithelial cell line","volume":"217","author":"Park","year":"2006","journal-title":"MCF-10A. Toxicology"},{"key":"10.1016\/j.cbi.2021.109521_bib69","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11695-007-9087-1","article-title":"IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients","volume":"17","author":"Garc\u00eda-Galiano","year":"2007","journal-title":"Obes. Surg."},{"key":"10.1016\/j.cbi.2021.109521_bib70","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-13-0112","article-title":"Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease","volume":"169","author":"D\u00f6cke","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cbi.2021.109521_bib71","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0016-5085(03)00696-6","article-title":"In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats","volume":"125","author":"Sun","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2021.109521_bib72","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.CCM.0000201901.30292.C2","article-title":"Interleukin-6 treatment reverses apoptosis and blunts susceptibility to intraperitoneal bacterial challenge following hemorrhagic shock","volume":"34","author":"Arikan","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cbi.2021.109521_bib73","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1080\/10715760600885432","article-title":"Up regulation of IL-6 by ischemic preconditioning in normal and fatty rat livers: association with reduction of oxidative stress","volume":"40","author":"Tacchini","year":"2006","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.cbi.2021.109521_bib74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.alcohol.2004.07.006","article-title":"Therapeutic potential of interleukin-6 in preventing obesity- and alcohol-associated fatty liver transplant failure","volume":"34","author":"Gao","year":"2004","journal-title":"Alcohol"},{"issue":"1","key":"10.1016\/j.cbi.2021.109521_bib75","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cyto.2015.05.031","article-title":"PPAR\u03b1\/\u03b3 agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats","volume":"75","author":"Zhang","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cbi.2021.109521_bib76","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1158\/1940-6207.CAPR-10-0317","article-title":"Celecoxib inhibits interleukin-6\/interleukin-6 receptor-induced JAK2\/STAT3 phosphorylation in human hepatocellular carcinoma cells","volume":"4","author":"Liu","year":"2011","journal-title":"Canc. Prev. Res."},{"key":"10.1016\/j.cbi.2021.109521_bib77","doi-asserted-by":"crossref","first-page":"11281","DOI":"10.1074\/jbc.M208470200","article-title":"Interleukin-6\/glycoprotein 130-dependent pathways are protective during liver regeneration","volume":"278","author":"Wuestefeld","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2021.109521_bib78","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1172\/JCI200317970","article-title":"Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms","volume":"112","author":"Haga","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cbi.2021.109521_bib79","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/toxsci\/kfv178","article-title":"Aryl hydrocarbon receptor activation synergistically induces lipopolysaccharide-mediated expression of proinflammatory chemokine (c-c motif) Ligand 20","volume":"148","author":"Lahoti","year":"2015","journal-title":"Toxicol. Sci."},{"issue":"6","key":"10.1016\/j.cbi.2021.109521_bib80","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.patbio.2015.07.010","article-title":"Protective effect of Fenofibrate in renal ischemia reperfusion injury: involved in suppressing kinase 2 (JAK2)\/transcription 3 (STAT3)\/p53 signaling activation","volume":"63","author":"Lv","year":"2015","journal-title":"Pathol. Biol."},{"key":"10.1016\/j.cbi.2021.109521_bib81","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejphar.2006.12.037","article-title":"Effect of PPARalpha activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes","volume":"561","author":"Murakami","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109521_bib82","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1210\/en.2007-0014","article-title":"Peroxisome proliferator-activated receptor alpha protects against obesity-induced hepatic inflammation","volume":"148","author":"Stienstra","year":"2007","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.cbi.2021.109521_bib83","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.toxlet.2013.11.003","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt\/GSK-3\u03b2\/cyclin D1 signaling pathway","volume":"224","author":"Xu","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2021.109521_bib84","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/toxsci\/kfq052","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin impairs an insulin signaling pathway through the induction of tumor necrosis factor-\u03b1 in adipocytes","volume":"115","author":"Nishiumi","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2021.109521_bib85","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1038\/sj.onc.1209553","article-title":"Activation of the dioxin\/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism","volume":"25","author":"Diry","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2021.109521_bib86","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/toxsci\/kfh228","article-title":"A critical role for MAP kinases in the control of Ah receptor complex activity","volume":"82","author":"Tan","year":"2004","journal-title":"Toxicol. Sci."},{"issue":"18","key":"10.1016\/j.cbi.2021.109521_bib87","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1111\/bph.13928","article-title":"Inhibition of JNK signaling mediates PPAR\u03b1-dependent protection against intrahepatic cholestasis by fenofibrate","volume":"174","author":"Dai","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109521_bib88","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cbi.2005.06.004","article-title":"Increased mortality associated with TCDD exposure in mice infected with influenza A virus is not due to severity of lung injury or alterations in Clara cell protein content","volume":"155","author":"Bohn","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2021.109521_bib89","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.bcp.2013.07.004","article-title":"The emerging roles of AhR in physiology and immunity","volume":"86","author":"Hao","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.cbi.2021.109521_bib90","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1538\/expanim.20-0028","article-title":"Gender difference in development of steatohepatitis in p62\/Sqstm1 and Nrf2 double-knockout mice","volume":"69","author":"Watahiki","year":"2020","journal-title":"Exp. Anim."},{"issue":"15","key":"10.1016\/j.cbi.2021.109521_bib91","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1113\/JP277270","article-title":"Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance","volume":"597","author":"Camporez","year":"2019","journal-title":"J Physiol"},{"issue":"9","key":"10.1016\/j.cbi.2021.109521_bib92","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.celrep.2017.10.110","article-title":"Testosterone attenuates group 2 innate lymphoid cell-mediated airway inflammation","volume":"21","author":"Cephus","year":"2017","journal-title":"Cell Rep."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721001575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279721001575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:05:52Z","timestamp":1757858752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279721001575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":92,"alternative-id":["S0009279721001575"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109521","relation":{},"ISSN":["0009-2797"],"issn-type":[{"type":"print","value":"0009-2797"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, blocks steatosis and alters the inflammatory response in a mouse model of inflammation-dioxin interaction","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109521"}}